The global mouth ulcer treatment market revenue was around US$ 1.34 billion in 2022 and is estimated to reach US$ 1.92 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period from 2023 to 2031.
Mouth ulcers are painful sores, breaks, or lesions that occur in the mucous membrane of the oral cavity's soft tissues, which include the cheeks, lips, tongue, gums, roof, and floor. It can also be seen in the esophagus. It is often undesirable light or yellow lesions with a crimson exterior ring that is painful and causes discomfort while eating and drinking food.
Market Driving Factors
The demand for mouth ulcer treatment has been on the increase owing to the surging prevalence of mouth ulcers due to an increase in tobacco consumption globally and smoking cessation, as smoking cessation generates mouth ulcers and happen often in smokers. Thus, this raises the occurrences of mouth ulcers owing to smoker's palate or tobacco stomatitis (inflammation of mucus membranes in the oral cavity), which is estimated to boost the market growth.
The increasing consciousness of oral hygiene and dental is driving the market growth. Oral health is an essential part of the general health and well-being of an individual. Additionally, antimicrobial dental materials based on antimicrobial agent release, contact-killing, and multi-functional methods have been prepared and synthesized for the avoidance of initial bacterial attachment and subsequent biofilm appearance on the tooth and material surface.
Lack of awareness regarding oral hygiene and the adoption of traditional medicines rather than pharmaceuticals in developing and underdeveloped nations may impede the market's growth.
Regional Analysis
North America dominated the market in terms of the largest revenue share in the market. In this region, the United States has witnessed a substantial surge in the prevalence of dental issues among its populace. This trend is largely attributed to elements including a tobacco dependency, tobacco dependency, traumatic incidents, heightened stress levels, and modifications in local immune responses.
Asia Pacific is estimated to dominate the market. This is due to the increasing awareness surrounding oral hygiene the endorsement of initiatives by governmental bodies and the leveraging of its substantial population base and progressively improving healthcare infrastructure. Furthermore, this region presents considerable untapped opportunities, alongside a mounting acknowledgment and adoption of branded products, which collectively contribute to the strong advancement in the region.
Segmentation Insights
Formulation Insight
The gels segment dominates the market in terms of the largest share. This is due to the widespread accessibility, swift healing formulations, and rapid effectiveness in combating swelling and inflammation. Furthermore, these gels provide anesthetic attributes, temporarily alleviating the extreme discomfort associated with sores. These gels prove to be a versatile solution with an array of flavors and designs catering to both adult and pediatric usage.
The sprays segment is estimated to dominate the market. This growth is mainly due to its minimal incidence of side effects, broad availability, and expedited healing capabilities for sores. The comfort of regular usage for mitigating harmful consequences also underscores its appeal. Furthermore, these formulations are preferred by adults owing to their lower chance of inducing unfavorable reactions in comparison to choices, assuring sustained safeguarding benefits.
Drug Class Insight
The analgesics and corticosteroids segment dominates the market in terms of the fastest rate. This is due to the high prescription prevalence of these products as pain-relieving agents worldwide. Specifically, their utilization as pain alleviators in the management of dental sores highlights their significance. In addition, corticosteroids exhibit anti-inflammatory attributes that effectively mitigate inflammation resulting from infections. Furthermore, these substances engage with intracellular receptors, inducing changes in gene expression, and ultimately inhibiting the microorganism's activity.
Prominent Companies
Segmentation Outline
The global mouth ulcer treatment market segmentation focuses on Formulation, Drug Class, and Region.
By Formulation
By Drug Class
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL MOUTH ULCER TREATMENT MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: MOUTH ULCER TREATMENT MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL MOUTH ULCER TREATMENT MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL MOUTH ULCER TREATMENT MARKET, BY FORMULATION
5.1 OVERVIEW
5.2 SPRAYS
5.3 MOUTHWASH
5.4 GELS
5.5 LOZENGES
6 GLOBAL MOUTH ULCER TREATMENT MARKET, BY DRUG CLASS
6.1 OVERVIEW
6.2 ANTIMICROBIAL
6.3 ANTIHISTAMINE
6.4 ANALGESICS & CORTICOSTEROIDS
6.5 OTHERS
7 GLOBAL MOUTH ULCER TREATMENT MARKET, BY GEOGRAPHY
7.1 OVERVIEW
7.2 NORTH AMERICA
7.2.1 NORTH AMERICA MARKET SNAPSHOT
7.2.2 U.S.
7.2.3 CANADA
7.2.4 MEXICO
7.3 EUROPE
7.3.1 EUROPE MARKET SNAPSHOT
7.3.2 WESTERN EUROPE
7.3.2.1 THE UK
7.3.2.2 GERMANY
7.3.2.3 FRANCE
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF WESTERN EUROPE
7.3.3 EASTERN EUROPE
7.3.3.1 POLAND
7.3.3.2 RUSSIA
7.3.3.3 REST OF EASTERN EUROPE
7.4 ASIA PACIFIC
7.4.1 ASIA PACIFIC MARKET SNAPSHOT
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 INDIA
7.4.5 AUSTRALIA & NEW ZEALAND
7.4.6 ASEAN
7.4.7 REST OF ASIA PACIFIC
7.5 MIDDLE EAST & AFRICA
7.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
7.5.2 UAE
7.5.3 SAUDI ARABIA
7.5.4 SOUTH AFRICA
7.5.5 REST OF MEA
7.6 SOUTH AMERICA
7.6.1 SOUTH AMERICA MARKET SNAPSHOT
7.6.2 BRAZIL
7.6.3 ARGENTINA
7.6.4 REST OF SOUTH AMERICA
8 GLOBAL MOUTH ULCER TREATMENT MARKET COMPETITIVE LANDSCAPE
8.1 OVERVIEW
8.2 COMPANY MARKET RANKING
8.3 KEY DEVELOPMENT STRATEGIES
8.4 COMPETITIVE DASHBOARD
8.5 PRODUCT MAPPING
8.6 TOP PLAYER POSITIONING, 2022
8.7 COMPETITIVE HEATMAP
8.8 TOP WINNING STRATEGIES
9 COMPANY PROFILES
9.1 3M
9.1.1 OVERVIEW
9.1.2 FINANCIAL PERFORMANCE
9.1.3 PRODUCT OUTLOOK
9.1.4 KEY DEVELOPMENTS
9.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.2 BLISTEX
9.2.1 OVERVIEW
9.2.2 FINANCIAL PERFORMANCE
9.2.3 PRODUCT OUTLOOK
9.2.4 KEY DEVELOPMENTS
9.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.3 BRISTOL MYERS
9.3.1 OVERVIEW
9.3.2 FINANCIAL PERFORMANCE
9.3.3 PRODUCT OUTLOOK
9.3.4 KEY DEVELOPMENTS
9.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.4 CHURCH & DWIGHT
9.4.1 OVERVIEW
9.4.2 FINANCIAL PERFORMANCE
9.4.3 PRODUCT OUTLOOK
9.4.4 KEY DEVELOPMENTS
9.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.5 COLGATE-PALMOLIVE
9.5.1 OVERVIEW
9.5.2 FINANCIAL PERFORMANCE
9.5.3 PRODUCT OUTLOOK
9.5.4 KEY DEVELOPMENTS
9.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.6 GLAXOSMITHKLINE
9.6.1 OVERVIEW
9.6.2 FINANCIAL PERFORMANCE
9.6.3 PRODUCT OUTLOOK
9.6.4 KEY DEVELOPMENTS
9.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
9.7 PFIZER
9.7.1 OVERVIEW
9.7.2 FINANCIAL PERFORMANCE
9.7.3 PRODUCT OUTLOOK
9.7.4 KEY DEVELOPMENTS
9.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
著作権 ©2022 無断複写・転載を禁じます